 The number of children and teenagers in the United States diagnosed with type 2 diabetes could rise by as much as 675 by 2060, which boosts the market. The dividend per share has risen steadily at 7.2 per year, and management is shareholder-friendly by buying back shares, further boosting the dividend per share. 